Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

2013 • 5,819 citations

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1995 • 4,310 citations

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1996 • 4,184 citations

Identification of a major co-receptor for primary isolates of HIV-1

1996 • 3,649 citations

Viral dynamics in human immunodeficiency virus type 1 infection

1995 • 3,277 citations

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1996 • 3,189 citations

Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection

1993 • 1,258 citations

Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection

1995 • 1,044 citations

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

1989 • 628 citations

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

1988 • 540 citations

Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection

1993 • 474 citations

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

1985 • 448 citations

Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission

1996 • 447 citations

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

1985 • 427 citations

Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120

1995 • 405 citations

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.

1995 • 334 citations

Follicular dendritic cells and human immunodeficiency virus infectivity

1995 • 313 citations

Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays

1994 • 300 citations

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates

1995 • 293 citations

Neutralizing and Infection-Enhancing Antibody Responses to Human Immunodeficiency Virus Type 1 in Long-Term Nonprogressors

1996 • 262 citations

HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN TWO COHORTS OF HOMOSEXUAL MEN: NEUTRALISING SERA AND ASSOCIATION OF ANTI-GAG ANTIBODY WITH PROGNOSIS

1987 • 249 citations

Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization

1994 • 241 citations

Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes

1996 • 222 citations

Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1

1994 • 219 citations

V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability

1993 • 210 citations

Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans

1993 • 208 citations

Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: Correlation with Neutralizing Antibodies against Primary Isolates

1993 • 178 citations

HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.

1995 • 170 citations

Two Antigenically Distinct Subtypes of Human Immunodeficiency Virus Type 1: Viral Genotype Predicts Neutralization Serotype

1994 • 161 citations

Predictors for Non- and Slow Progression in Human Immunodeficiency Virus (HIV) Type 1 Infection: Low Viral RNA Copy Numbers in Serum and Maintenance of High HIV-1 p24-Specific but Not V3-Specific Antibody Levels

1995 • 144 citations

Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera

1995 • 143 citations

Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection

1994 • 130 citations

Differential Role of V3-Specific Antibodies in Neutralization Assays Involving Primary and Laboratory-Adapted Isolates of HIV Type 1

1995 • 118 citations

Antibody neutralization of HIV-1

1996 • 95 citations

Multivariate analysis of human immunodeficiency virus type 1 neutralization data

1996 • 94 citations

Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1

1994 • 92 citations

Autologous Neutralizing Antibodies Prevail in HIV-2 but Not in HIV-1 Infection

1993 • 91 citations

The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.

1994 • 88 citations

Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus.

1994 • 87 citations

Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system

1994 • 73 citations

Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1

1996 • 72 citations

Jitters Jeopardize AIDS Vaccine Trials

1993 • 70 citations

Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro

1995 • 69 citations

A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity

1994 • 63 citations

Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?

1992 • 61 citations

Can the immune response control HIV infection?

1995 • 61 citations

Kinetics of Appearance of Neutralizing Antibodies in 12 Patients with Primary or Recent HIV-1 Infection and Relationship with Plasma and Cellular Viral Loads

1996 • 59 citations

Demise of the Atelocerata?

1995 • 58 citations

Antibody Responses to HIV-1 Envelope and GAG Epitopes in HIV-1 Seroconverters with Rapid versus Slow Disease Progression

1994 • 58 citations

Neutralization of HIV-1

1994 • 57 citations

A Resting Cell Assay for Improved Detection of Antibody-Mediated Neutralization of HIV Type 1 Primary Isolates

1995 • 55 citations

Comparative studies on use of fresh and frozen peripheral blood lymphocyte specimens for isolation of human immunodeficiency virus and effects of cell lysis on isolation efficiency

1987 • 45 citations

Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120

1993 • 45 citations

Neutralizing Antibodies Against Sequential Autologous Human Immunodeficiency Virus Type 1 Isolates After Seroconversion

1994 • 42 citations

Neutralization of Primary Human Immunodeficiency Virus Type 1 Isolates: A Study of Parameters Implicated in Neutralizationin Vitro

1997 • 35 citations

Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum

1994 • 34 citations

Development of HIV-1 group-specific neutralizing antibodies after seroconversion

1992 • 31 citations

Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses

1996 • 30 citations

Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge

1994 • 27 citations

Intrapatient Variability of the Human Immunodeficiency Virus Type 2 Envelope V3 Loop

1995 • 26 citations

Frequent and Early HIV-1_MNNeutralizing Capacity in Sera from Dutch HIV-1 Seroconverters Is Related to Antibody Reactivity to Peptides from the gp120 V3 Domain

1994 • 25 citations

Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS

1996 • 22 citations

Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans

1993 • 10 citations

Sequence variation within the human immunodeficiency virus V3 loop at seroconversion

1993 • 10 citations

The HIV-1 V3 domain on field isolates: participation in generation of escape virus in vivo and accessibility to neutralizing antibodies

1995 • 9 citations

Immunologic escape as a mechanism of viral persistence in HIV-1 infection

1994 • 5 citations

Analysis of B Cell Repertoire Specific to the Neutralizing Epitopes of Glycoprotein 120 in HIV-Infected Individuals

1994 • 4 citations